Global Intravesical Bacillus Calmette Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Market Overview
- 1.1 Intravesical Bacillus Calmette Introduction
- 1.2 Market Analysis by Type
- 1.2.1 40mg/Vial
- 1.2.2 50mg/Vial
- 1.2.3 60mg/Vial
- 1.2.4 80mg/Vial
- 1.3 Market Analysis by Applications
- 1.3.1 Hospitals
- 1.3.2 Clinics
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Business Overview
- 2.1.2 Intravesical Bacillus Calmette Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Merck Intravesical Bacillus Calmette Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Japan BCG Laboratory
- 2.2.1 Business Overview
- 2.2.2 Intravesical Bacillus Calmette Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Japan BCG Laboratory Intravesical Bacillus Calmette Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 China National Biotec
- 2.3.1 Business Overview
- 2.3.2 Intravesical Bacillus Calmette Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 China National Biotec Intravesical Bacillus Calmette Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Serum Institute of India
- 2.4.1 Business Overview
- 2.4.2 Intravesical Bacillus Calmette Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Serum Institute of India Intravesical Bacillus Calmette Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 GSBPL
- 2.5.1 Business Overview
- 2.5.2 Intravesical Bacillus Calmette Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 GSBPL Intravesical Bacillus Calmette Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Intravesical Bacillus Calmette Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Intravesical Bacillus Calmette Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Intravesical Bacillus Calmette Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Intravesical Bacillus Calmette Manufacturer Market Share in 2018
- 3.3.2 Top 6 Intravesical Bacillus Calmette Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Intravesical Bacillus Calmette Market Analysis by Regions
- 4.1 Global Intravesical Bacillus Calmette Sales, Revenue and Market Share by Regions
- 4.1.1 Global Intravesical Bacillus Calmette Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Intravesical Bacillus Calmette Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 4.3 Europe Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 4.5 South America Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
5 North America Intravesical Bacillus Calmette by Country
- 5.1 North America Intravesical Bacillus Calmette Sales, Revenue and Market Share by Country
- 5.1.1 North America Intravesical Bacillus Calmette Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Intravesical Bacillus Calmette Revenue and Market Share by Country (2014-2019)
- 5.2 United States Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 5.3 Canada Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 5.4 Mexico Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
6 Europe Intravesical Bacillus Calmette by Country
- 6.1 Europe Intravesical Bacillus Calmette Sales, Revenue and Market Share by Country
- 6.1.1 Europe Intravesical Bacillus Calmette Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Intravesical Bacillus Calmette Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 6.3 UK Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 6.4 France Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 6.5 Russia Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 6.6 Italy Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
7 Asia-Pacific Intravesical Bacillus Calmette by Country
- 7.1 Asia-Pacific Intravesical Bacillus Calmette Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Intravesical Bacillus Calmette Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Intravesical Bacillus Calmette Revenue and Market Share by Country (2014-2019)
- 7.2 China Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 7.3 Japan Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 7.4 Korea Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 7.5 India Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
8 South America Intravesical Bacillus Calmette by Country
- 8.1 South America Intravesical Bacillus Calmette Sales, Revenue and Market Share by Country
- 8.1.1 South America Intravesical Bacillus Calmette Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Intravesical Bacillus Calmette Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 8.3 Argentina Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 8.4 Colombia Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
9 Middle East and Africa Intravesical Bacillus Calmette by Countries
- 9.1 Middle East and Africa Intravesical Bacillus Calmette Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Intravesical Bacillus Calmette Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Intravesical Bacillus Calmette Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 9.3 Turkey Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 9.4 Egypt Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
- 9.6 South Africa Intravesical Bacillus Calmette Sales and Growth Rate (2014-2019)
10 Global Intravesical Bacillus Calmette Market Segment by Type
- 10.1 Global Intravesical Bacillus Calmette Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Intravesical Bacillus Calmette Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Intravesical Bacillus Calmette Revenue and Market Share by Type (2014-2019)
- 10.2 40mg/Vial Sales Growth and Price
- 10.2.1 Global 40mg/Vial Sales Growth (2014-2019)
- 10.2.2 Global 40mg/Vial Price (2014-2019)
- 10.3 50mg/Vial Sales Growth and Price
- 10.3.1 Global 50mg/Vial Sales Growth (2014-2019)
- 10.3.2 Global 50mg/Vial Price (2014-2019)
- 10.4 60mg/Vial Sales Growth and Price
- 10.4.1 Global 60mg/Vial Sales Growth (2014-2019)
- 10.4.2 Global 60mg/Vial Price (2014-2019)
- 10.5 80mg/Vial Sales Growth and Price
- 10.5.1 Global 80mg/Vial Sales Growth (2014-2019)
- 10.5.2 Global 80mg/Vial Price (2014-2019)
11 Global Intravesical Bacillus Calmette Market Segment by Application
- 11.1 Global Intravesical Bacillus Calmette Sales Market Share by Application (2014-2019)
- 11.2 Hospitals Sales Growth (2014-2019)
- 11.3 Clinics Sales Growth (2014-2019)
12 Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.1 Global Intravesical Bacillus Calmette Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Intravesical Bacillus Calmette Market Forecast by Regions (2019-2024)
- 12.2.1 North America Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.2.2 Europe Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.2.4 South America Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Intravesical Bacillus Calmette Market Forecast (2019-2024)
- 12.3 Intravesical Bacillus Calmette Market Forecast by Type (2019-2024)
- 12.3.1 Global Intravesical Bacillus Calmette Sales Forecast by Type (2019-2024)
- 12.3.2 Global Intravesical Bacillus Calmette Market Share Forecast by Type (2019-2024)
- 12.4 Intravesical Bacillus Calmette Market Forecast by Application (2019-2024)
- 12.4.1 Global Intravesical Bacillus Calmette Sales Forecast by Application (2019-2024)
- 12.4.2 Global Intravesical Bacillus Calmette Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Scope of the Report:
In the last several years, Global market of Intravesical Bacillus Calmette developed rapidly, with an average growth rate of 5.33%. In 2018, after a huge decrease and recovery, Global revenue of Intravesical Bacillus Calmette is about 198 M USD.
Since 2017, Sanofi start to shut down its production facility, which caused a large short in the market. On the other hand, other manufacturers like Merck are expanding their capacity to fulfill the market demand.
North America region is the largest consumption of Intravesical Bacillus Calmette, with a sales revenue market share nearly 47.7% in 2018. Europe is the second largest consumer of Intravesical Bacillus Calmette, enjoying sales revenue market share about 35.5% in 2016.
The worldwide market for Intravesical Bacillus Calmette is expected to grow at a CAGR of roughly 8.4% over the next five years, will reach 330 million US$ in 2024, from 220 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Intravesical Bacillus Calmette in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Japan BCG Laboratory
China National Biotec
Serum Institute of India
GSBPL
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
40mg/Vial
50mg/Vial
60mg/Vial
80mg/Vial
Market Segment by Applications, can be divided into
Hospitals
Clinics
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravesical Bacillus Calmette product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravesical Bacillus Calmette, with price, sales, revenue and global market share of Intravesical Bacillus Calmette in 2017 and 2018.
Chapter 3, the Intravesical Bacillus Calmette competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravesical Bacillus Calmette breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Intravesical Bacillus Calmette market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Intravesical Bacillus Calmette sales channel, distributors, customers, research findings and conclusion, appendix and data source.